Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2012 1
2015 3
2016 3
2017 2
2018 1
2019 3
2020 10
2021 3
Text availability
Article attribute
Article type
Publication date

Search Results

22 results
Results by year
Filters applied: . Clear all
Page 1
Interferon Beta-1b and Lopinavir-Ritonavir for Middle East Respiratory Syndrome.
Arabi YM, Asiri AY, Assiri AM, Balkhy HH, Al Bshabshe A, Al Jeraisy M, Mandourah Y, Azzam MHA, Bin Eshaq AM, Al Johani S, Al Harbi S, Jokhdar HAA, Deeb AM, Memish ZA, Jose J, Ghazal S, Al Faraj S, Al Mekhlafi GA, Sherbeeni NM, Elzein FE, Al-Hameed F, Al Saedi A, Alharbi NK, Fowler RA, Hayden FG, Al-Dawood A, Abdelzaher M, Bajhmom W, AlMutairi BM, Hussein MA, Alothman A; Saudi Critical Care Trials Group. Arabi YM, et al. Among authors: alharbi nk. N Engl J Med. 2020 Oct 22;383(17):1645-1656. doi: 10.1056/NEJMoa2015294. Epub 2020 Oct 7. N Engl J Med. 2020. PMID: 33026741 Clinical Trial.
Humoral Immunogenicity and Efficacy of a Single Dose of ChAdOx1 MERS Vaccine Candidate in Dromedary Camels.
Alharbi NK, Qasim I, Almasoud A, Aljami HA, Alenazi MW, Alhafufi A, Aldibasi OS, Hashem AM, Kasem S, Albrahim R, Aldubaib M, Almansour A, Temperton NJ, Kupke A, Becker S, Abu-Obaidah A, Alkarar A, Yoon IK, Azhar E, Lambe T, Bayoumi F, Aldowerij A, Ibrahim OH, Gilbert SC, Balkhy HH. Alharbi NK, et al. Sci Rep. 2019 Nov 8;9(1):16292. doi: 10.1038/s41598-019-52730-4. Sci Rep. 2019. PMID: 31705137 Free PMC article.
Early Humoral Response Correlates with Disease Severity and Outcomes in COVID-19 Patients.
Hashem AM, Algaissi A, Almahboub SA, Alfaleh MA, Abujamel TS, Alamri SS, Alluhaybi KA, Hobani HI, AlHarbi RH, Alsulaiman RM, ElAssouli MZ, Hala S, Alharbi NK, Alhabbab RY, AlSaieedi AA, Abdulaal WH, Bukhari A, Al-Somali AA, Alofi FS, Khogeer AA, Pain A, Alkayyal AA, Almontashiri NAM, Ahmad BM, Li X. Hashem AM, et al. Among authors: alharbi nk. Viruses. 2020 Dec 4;12(12):1390. doi: 10.3390/v12121390. Viruses. 2020. PMID: 33291713 Free PMC article.
A Highly Immunogenic, Protective, and Safe Adenovirus-Based Vaccine Expressing Middle East Respiratory Syndrome Coronavirus S1-CD40L Fusion Protein in a Transgenic Human Dipeptidyl Peptidase 4 Mouse Model.
Hashem AM, Algaissi A, Agrawal AS, Al-Amri SS, Alhabbab RY, Sohrab SS, S Almasoud A, Alharbi NK, Peng BH, Russell M, Li X, Tseng CK. Hashem AM, et al. J Infect Dis. 2019 Oct 8;220(10):1558-1567. doi: 10.1093/infdis/jiz137. J Infect Dis. 2019. PMID: 30911758 Free PMC article.
Challenge infection model for MERS-CoV based on naturally infected camels.
Alharbi NK, Ibrahim OH, Alhafufi A, Kasem S, Aldowerij A, Albrahim R, Abu-Obaidah A, Alkarar A, Bayoumi FA, Almansour AM, Aldubaib M, Al-Abdely HM, Balkhy HH, Qasim I. Alharbi NK, et al. Virol J. 2020 Jun 17;17(1):77. doi: 10.1186/s12985-020-01347-5. Virol J. 2020. PMID: 32552831 Free PMC article.
Seroprevalence of MERS-CoV in healthy adults in western Saudi Arabia, 2011-2016.
Degnah AA, Al-Amri SS, Hassan AM, Almasoud AS, Mousa M, Almahboub SA, Alhabbab RY, Mirza AA, Hindawi SI, Alharbi NK, Azhar EI, Hashem AM. Degnah AA, et al. J Infect Public Health. 2020 May;13(5):697-703. doi: 10.1016/j.jiph.2020.01.001. Epub 2020 Jan 28. J Infect Public Health. 2020. PMID: 32005618 Free PMC article.
Transcriptomics-Based Characterization of the Toxicity of ZnO Nanoparticles Against Chronic Myeloid Leukemia Cells.
Alsagaby SA, Vijayakumar R, Premanathan M, Mickymaray S, Alturaiki W, Al-Baradie RS, AlGhamdi S, Aziz MA, Alhumaydhi FA, Alzahrani FA, Alwashmi AS, Al Abdulmonem W, Alharbi NK, Pepper C. Alsagaby SA, et al. Int J Nanomedicine. 2020 Oct 13;15:7901-7921. doi: 10.2147/IJN.S261636. eCollection 2020. Int J Nanomedicine. 2020. PMID: 33116508 Free PMC article.
22 results
You have reached the last page of results. A maximum of 10,000 results are available.
Jump to page